|
 
 |
| ERRATUM |
|
| Year : 2021 | Volume
: 7
| Issue : 2 | Page : 145 |
|
Erratum: Risk factors for focal osteolysis in a stainless-steel limb-lengthening device
| Date of Web Publication | 30-Dec-2021 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2455-3719.335951
How to cite this article:
. Erratum: Risk factors for focal osteolysis in a stainless-steel limb-lengthening device. J Limb Lengthen Reconstr 2021;7:145 |
In the article titled “Risk factors for focal osteolysis in a stainless-steel limb-lengthening device”, published on pages 19-25, Issue 1, Volume 7 in Journal of Limb Lengthening & Reconstruction,[1] the following paragraph was missing under the section Financial support and sponsorship.
JDC is a consultant for Bonesupport, Orthofix, Smith+Nephew, and Zimmer Biomet, receives fellowship support from Biocomposites, is on the MicroGenDX Advisory Board, and her spouse receives royalties from the University of Florida. SCS is a consultant for NuVasive Specialized Orthopedics and Smith+Nephew, and receives royalties from NuVasive Specialized Orthopedics, Pega Medical, and Smith+Nephew. MA is an unpaid consultant for Johnson & Johnson, OrthoPediatrics, and Orthofix. JEH is a clinical advisor for Bonus BioGroup and a consultant for NuVasive Specialized Orthopedics, Orthofix, OrthoPediatrics, OrthoSpin, Smith+Nephew, and WishBone Medical. PKM is a consultant for DePuy Synthes Companies, Novadip, Orthofix, and Smith+Nephew. The following organizations supported the institution of OCS, JDC, SCS, MA, JEH, and PKM: Biocomposites, DePuy Synthes Companies, MHE Coalition, Orthofix, OrthoPediatrics, Pega Medical, Smith+Nephew, Stryker, and Zimmer Biomet.
| References | |  |
|
